title: Brief report: tumor lysis syndrome following treatment with 2-chlorodeoxyadenosine for refractory chronic lymphocytic leukemia.
authors.affiliation: Department of Hematology, Hadassah University Hospital, Ein Kerem, Jerusalem, Israel.
authors.forename: E J
authors.initials: EJ
authors.lastname: Dann
authors.forename: S
authors.initials: S
authors.lastname: Gillis
authors.forename: A
authors.initials: A
authors.lastname: Polliack
authors.forename: E
authors.initials: E
authors.lastname: Okon
authors.forename: D
authors.initials: D
authors.lastname: Rund
authors.forename: E A
authors.initials: EA
authors.lastname: Rachmilewitz
mesh_terms: D017338:Cladribine / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D008206:Lymphatic Diseases / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D015275:Tumor Lysis Syndrome / Q000209:etiology*
chemical_list: D017338:Cladribine